Arzu Onar-Thomas

7PUBLICATIONS
55CO-AUTHORS
Infant and child healthPredictive and prognostic markersHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

|Apr 17, 2025
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.

Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint

|Apr 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastoma.

Alexa N Siskar, Emily Hanzlik, Maria F Cardenas

|Mar 22, 2025
Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial.

Heather M Conklin, Nicole A Salman, Johnnie K Bass

|Nov 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study.

Matthias A Karajannis, Arzu Onar-Thomas, Tong Lin

|Feb 25, 2022
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.

S Vajapeyam, D Brown, A Ziaei

Pageof 2

Frequent Collaborators

4 joint publications

Jason Fangusaro

4 joint publications

Ira J Dunkel

3 joint publications

Maryam Fouladi

3 joint publications

Tina Young Poussaint